A-A-0053374(DM)
1 March 1988
INTERIM COMMERCIAL ITEM DESCRIPTION
LIOTRIX TABLETS, USP
The General Services Administration has authorized the use of this Interim Commercial Item Description which was developed by the Defense Personnel Support Center, Directorate of Medical Materiel, DPSC-RST, 2800 South 20th Street, Philadelphia, PA 19101, based upon currently available technical information.
Salient characteristics:
Shall be Liotrix Tablets, USP.
Shall be in accordance with the requirments of the USP.
Each tablet shall contain 60 micrograms (mcg) of Levothyroxin Sodium, USP, and 15 mcg of Liothyronine Sodium, USP, wihtin the applicable assay limits.
All ingredients entering into the formulation of the tablets shall be of pharmaceutical grade.
Each tablet shall be marked/embossed with a product identification code to identify the active ingredient(s), strength, and manufacturer. The materials used in marking/embossing the dosage forms shall be acceptable to the FDA. The actual code used for the product shall be left to the discretion of the supplier.
Workmanship. The tablets shall be free from defects which detract from their appearance or impair their serviceability.
Unit. Bottle (BT). One bottle containing 100 tablets, as specified, constitutes one unit.
DISTRIBUTION STATEMENT A. Approved for public release; distribution is unlimited.
For Parts Inquires submit RFQ to Parts Hangar, Inc.
© Copyright 2015 Integrated Publishing, Inc.
A Service Disabled Veteran Owned Small Business